Elite Pharmaceuticals (ELTP) Capital Expenditures (2010 - 2026)
Elite Pharmaceuticals (ELTP) reported Capital Expenditures of $808,964 for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 270.7% from $218,204 a year earlier and up 103.2% from the prior quarter.
Elite Pharmaceuticals (ELTP) Capital Expenditures (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Elite Pharmaceuticals' Capital Expenditures came in at $1.52 million, up 42.4% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $925,626, down 43.0% from FY2025.
- Capital Expenditures has a five-year compound annual growth rate of 22.9% (FY2021 to FY2026).
- By fiscal year, Capital Expenditures came in at $1.63 million in FY2025 (+100.7%), $809,653 in FY2024 (-85.9%), $5.74 million in FY2023 and $498,566 in FY2022 (+51.1%).
- The fiscal Q1 2027 figure ranks as the highest quarterly Capital Expenditures since fiscal Q2 2023.
- Year over year, Capital Expenditures gained in three of the last five quarters, with growth averaging 50.0%.
- The high point for year-over-year Capital Expenditures in five years was fiscal Q1 2027 (growth of 270.7%); the low point was fiscal Q3 2023 (a decline of 99.1%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $398,016 (Q4 2026), $206,072 (Q3 2026) and $103,334 (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | 808,964.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 808,964.00 |
| Mar 31, 2026 | 398,016.00 |
| Dec 31, 2025 | 206,072.00 |
| Sep 30, 2025 | 103,334.00 |
| Jun 30, 2025 | 218,204.00 |
| Mar 31, 2025 | 754,110.00 |
| Sep 30, 2024 | 92,445.00 |
| Jun 30, 2024 | 778,527.00 |
| Mar 31, 2024 | 403,646.00 |
| Mar 31, 2023 | 536,211.00 |
| Dec 31, 2022 | 711.00 |
| Sep 30, 2022 | 5.11 Mn |
| Jun 30, 2022 | 94,597.00 |
| Mar 31, 2022 | 264,179.00 |
| Dec 31, 2021 | 82,076.00 |
| Sep 30, 2021 | 147,361.00 |
| Jun 30, 2021 | 4,950.00 |
| Mar 31, 2021 | 184,902.00 |
| Dec 31, 2020 | 50,231.00 |
| Sep 30, 2020 | 80,848.00 |
Elite Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();